Unverified50% confidenceFactExact time
Most countries classify AI involved in diagnosis and treatment decisions as medical device software, which must go through the corresponding approval pathway.
1
Sources
50%
Confidence
Long-term
Relevance
11/1/2026
First Seen
Sources
Related Entities
Related Claims
VerifiedUnder the major global regulatory frameworks, medical AI products are classified as Software as a Medical Device (SaMD); the U.S. FDA requires clearance through the 510(k) or PMA process, China's NMPA requires completion of Class III medical device registration, and the EU regulates them through the MDR.80% similarUnverifiedUsers should treat such AI medical tools as supplementary references rather than final decision-making authorities, and should consult professionals or contact their insurer for significant medical and financial matters.78% similarUnverifiedThe current mainstream consensus is that medical AI should serve as an assistive tool for doctors rather than an independent diagnostician.74% similarUnverifiedIn the United States, diagnosis, prescribing and administering tests must all be performed by licensed clinicians, and AI itself does not hold a medical license.72% similar
Cite This Claim
Stable URI
https://kongchang.com/claim/1123073API
curl https://kongchang.com/api/v1/knowledge/claims/1123073MCP
get_claim(id=1123073)